Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Other Working Capital Changes: 2017-2025

Historic Other Working Capital Changes for Puma Biotechnology (PBYI) over the last 9 years, with Sep 2025 value amounting to $84,000.

  • Puma Biotechnology's Other Working Capital Changes rose 108.37% to $84,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $989,000, marking a year-over-year increase of 139.25%. This contributed to the annual value of -$1.0 million for FY2024, which is 34.08% up from last year.
  • Per Puma Biotechnology's latest filing, its Other Working Capital Changes stood at $84,000 for Q3 2025, which was up 106.64% from -$1.3 million recorded in Q2 2025.
  • Puma Biotechnology's Other Working Capital Changes' 5-year high stood at $4.7 million during Q2 2022, with a 5-year trough of -$6.0 million in Q4 2022.
  • In the last 3 years, Puma Biotechnology's Other Working Capital Changes had a median value of -$138,000 in 2023 and averaged -$264,545.
  • Within the past 5 years, the most significant YoY rise in Puma Biotechnology's Other Working Capital Changes was 4,420.95% (2022), while the steepest drop was 150,650.00% (2022).
  • Quarterly analysis of 5 years shows Puma Biotechnology's Other Working Capital Changes stood at -$4,000 in 2021, then slumped by 150,650.00% to -$6.0 million in 2022, then spiked by 97.71% to -$138,000 in 2023, then spiked by 1,101.45% to $1.4 million in 2024, then spiked by 108.37% to $84,000 in 2025.
  • Its last three reported values are $84,000 in Q3 2025, -$1.3 million for Q2 2025, and $789,000 during Q1 2025.